Zerlasiran
Zerlasiran is an investigational new drug that is being evaluated to treat atherosclerotic cardiovascular disease.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zerlasiran is an investigational new drug that is being evaluated to treat atherosclerotic cardiovascular disease. It is small interfering RNA (siRNA) drug candidate designed to reduce levels of lipoprotein(a).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1362353093 under CC BY-SA 4.0; modifications have been made.